Evidence map›Paper›PMID 31722416›Full record

ArticleNucleic acids research2020

MEGARes 2.0: a database for classification of antimicrobial drug, biocide and metal resistance determinants in metagenomic sequence data.

Enrique Doster, Steven M Lakin, Christopher J Dean, Cory Wolfe, Jared G Young, Christina Boucher, Keith E Belk, Noelle R Noyes, Paul S Morley

Abstract read
In one paragraph

Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 255 papers.

0numbers the graph read from it
0cells of the map it votes in
255citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

255 citing papers in PubMed.

  1. Trial
  2. Artificial intelligence catalyzes antimicrobial peptide design.Synthetic and systems biotechnology · 2027
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Exploring clonality ofMicrobiology spectrum · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Genetic analysis ofiScience · 2026
    Article

195 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Enrique DosterVeterinary Education, Research, and Outreach (VERO) Program, Texas A&M University and West Texas A&M University, Canyon, TX 79016, USA.
Steven M LakinDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Christopher J DeanDepartment of Veterinary Population Medicine, University of Minnesota, St. Paul, MN 55455, USA.
Cory WolfeDepartment of Clinical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Jared G YoungVeterinary Education, Research, and Outreach (VERO) Program, Texas A&M University and West Texas A&M University, Canyon, TX 79016, USA.
Christina BoucherDepartment of Computer and Information Science and Engineering, University of Florida, Gainesville, FL 32611, USA.
Keith E BelkDepartment of Animal Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Noelle R NoyesDepartment of Veterinary Population Medicine, University of Minnesota, St. Paul, MN 55455, USA.
Paul S MorleyVeterinary Education, Research, and Outreach (VERO) Program, Texas A&M University and West Texas A&M University, Canyon, TX 79016, USA.

Funding

Developing Computational Methods for Surveillance of Antimicrobial Resistant AgentsR01AI141810 · NIAID · UNIVERSITY OF FLORIDA · PI BOUCHER, CHRISTINA, PROSPERI, MATTIA · 2019 to 2023
$2.1M
Veterinary Pre-Doctoral Research Scholars ProgramT32OD012201 · OD · COLORADO STATE UNIVERSITY · PI VANDEWOUDE, SUE · 2013 to 2019
$795k
NIAID NIH HHS R01 AI141810NIH HHS T32 OD012201
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a threat to global public health and the identification of genetic determinants of AMR is a critical component to epidemiological investigations. High-throughput sequencing (HTS) provides opportunities for investigation of AMR across all microbial genomes in a sample (i.e. the metagenome). Previously, we presented MEGARes, a hand-curated AMR database and annotation structure developed to facilitate the analysis of AMR within metagenomic samples (i.e. the resistome). Along with MEGARes, we released AmrPlusPlus, a bioinformatics pipeline that interfaces with MEGARes to identify and quantify AMR gene accessions contained within a metagenomic sequence dataset. Here, we present MEGARes 2.0 (https://megares.meglab.org), which incorporates previously published resistance sequences for antimicrobial drugs, while also expanding to include published sequences for metal and biocide resistance determinants. In MEGARes 2.0, the nodes of the acyclic hierarchical ontology include four antimicrobial compound types, 57 classes, 220 mechanisms of resistance, and 1,345 gene groups that classify the 7,868 accessions. In addition, we present an updated version of AmrPlusPlus (AMR ++ version 2.0), which improves accuracy of classifications, as well as expanding scalability and usability.

Indexed as

Databases, GeneticDatabases, PharmaceuticalDrug Resistance, MicrobialGenes, BacterialSoftwareAnti-Infective AgentsBacteriaDisinfectantsMetagenomeMetagenomicsMetalsAnti-Infective AgentsDisinfectantsMetals

Identifiers

PMID31722416
PMCPMC7145535

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.